Midazolam

CAS 59467-70-8 8 FDA-DMF suppliersSmall Molecule

Overview

Midazolam is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL655).

API suppliers (7)

Suppliers of Midazolam backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • CAMBREX PROFARMACO MILANO SRLItaly2 active DMF
  • WAVELENGTH ENTERPRISES LTDIsrael1 active DMF
  • WAVELENGTH ENTERPRISES LTDIsrael1 active DMF
  • COHANCE LIFESCIENCES LTD1 active DMF
  • WAVELENGTH ENTERPRISES LTDIsrael1 active DMF
  • ABBOTT LABORATORIES HOSP PRODUCTS DIV
  • DIOSYNTH BV

Patent & exclusivity (US)

Per the FDA Orange Book (40 approved US products), the latest listed US patent on Midazolam expires 19 Jun 2038 and exclusivity 16 May 2026. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name
8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
Canonical SMILES
CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F
InChIKey
DDLIGBOFAVUZHB-UHFFFAOYSA-N

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo